Collectively, SI-2 treatment also recruited cytotoxic immune cells (CD4 + T cells and NK cells) and then generated a tumor-suppressing TIME to suppress 4T1 breast tumor progression in immune-intact female mice. Here, CD4 is linked to breast neoplasm.